Consider pregnancy

Data about the safety of direct-acting antiviral drugs in pregnancy are limited. Pregnancy should be avoided during hepatitis C treatment, and starting hepatitis C treatment in pregnant females is not recommended.

If a patient becomes pregnant during treatment, the decision to continue treatment should be made on a case-by-case basis—seek expert advice.